Department of Surgery, Brody School of Medicine, East Carolina University, Greenville, North Carolina.
Surgical Oncology, Ridley-Tree Cancer Center, Sansum Clinic, Santa Barbara, California.
Breast J. 2020 Feb;26(2):149-154. doi: 10.1111/tbj.13624. Epub 2019 Sep 8.
We aimed to describe the presentation and treatment of lactational phlegmon, a unique complication of mastitis in breastfeeding women that may require surgical management. We retrospectively analyzed medical charts of breastfeeding women treated by a single breast surgeon for lactational phlegmon or the related conditions of abscess or uncomplicated mastitis (UM) from July 2016 to October 2018. Demographic variables and treatment details were analyzed using ANOVA and Pearson's Chi-square test. Ten women with lactational phlegmon (19.2%), 15 women with abscess (28.8%), and 27 women with UM (51.9%) were identified. Phlegmon presented as a tender, erythematous, and nonfluctuant mass in a ductal distribution. Ultrasonography demonstrated an ill-defined, complex fluid collection. Epidemiologically, women with phlegmon were similar to patients with abscess and UM. Women with phlegmon reported more intense deep breast massage than patients in the other two groups, but significantly lower rates of breast pump use than women with abscess (30.0% vs 80.0%, P < .05). Relative to women with UM, patients with complicated mastitis (CM, defined as phlegmon or abscess) reported greater utilization of nipple shields (36.0% vs 11.1%, P < .05). Treatment of phlegmon entailed effective milk removal, antibiotics (range 10-30 days), and close follow-up until both clinical and radiographic resolution (range 8 days to >3 months), with biopsy of persistent masses. Antibiotic duration was significantly longer for patients with phlegmon compared to those with UM (mean 15.0 days vs 9.7 days, P < .05). Two phlegmons coalesced into abscesses within 1 week of diagnosis. Lactational phlegmon is a complication of mastitis in breastfeeding women that is distinct from abscess and UM. Optimal treatment consists of an extended course of antibiotics and close follow-up to monitor for coalescence into a drainable fluid collection and/or persistence of mass requiring biopsy.
我们旨在描述哺乳期胸壁脓肿的临床表现和治疗方法,这是哺乳期乳腺炎的一种独特并发症,可能需要手术治疗。我们回顾性分析了 2016 年 7 月至 2018 年 10 月期间由同一位乳腺外科医生治疗的哺乳期胸壁脓肿或相关脓肿或单纯性乳腺炎(UM)的母乳喂养妇女的病历。使用 ANOVA 和 Pearson's Chi-square 检验分析人口统计学变量和治疗细节。确定了 10 例哺乳期胸壁脓肿(19.2%)、15 例脓肿(28.8%)和 27 例 UM(51.9%)的妇女。胸壁脓肿表现为导管分布的触痛、红斑和非波动性肿块。超声检查显示界限不清的复杂液体积聚。从流行病学角度来看,胸壁脓肿患者与脓肿和 UM 患者相似。胸壁脓肿患者报告的深部乳房按摩比其他两组患者更剧烈,但与脓肿患者相比,使用吸奶器的比例明显较低(30.0%对 80.0%,P<.05)。与 UM 患者相比,复杂乳腺炎(CM,定义为胸壁脓肿或脓肿)患者报告乳头保护罩的使用率更高(36.0%对 11.1%,P<.05)。胸壁脓肿的治疗包括有效排乳、抗生素(10-30 天)和密切随访,直到临床和影像学缓解(8-3 个月),并对持续存在的肿块进行活检。与 UM 患者相比,胸壁脓肿患者的抗生素治疗时间明显更长(平均 15.0 天对 9.7 天,P<.05)。2 例胸壁脓肿在诊断后 1 周内合并为脓肿。哺乳期胸壁脓肿是哺乳期乳腺炎的一种并发症,与脓肿和 UM 不同。最佳治疗方法包括延长抗生素疗程,并密切随访,以监测是否合并为可引流的液体积聚和/或需要活检的肿块持续存在。